echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Study of Nervous System > The Instruction of Carbidopa monohydrate

    The Instruction of Carbidopa monohydrate

    • Last Update: 2023-05-12
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    Carbidopa monohydrate is a pharmaceutical drug that is primarily used to treat Parkinson's disease.
    It is also used to treat certain other movement disorders, such as dystonia and Huntington's disease.
    In the chemical industry, carbidopa monohydrate is used as an intermediate in the production of other chemicals and pharmaceuticals.


    To produce carbidopa monohydrate, the starting material is L-dopa, which is an amino acid that is found naturally in certain plants and animals.
    L-dopa is converted into carbidopa monohydrate through a series of chemical reactions, which involve the use of various chemical reagents and catalysts.


    The first step in the synthesis of carbidopa monohydrate is the conversion of L-dopa into a pre-cursor compound called 3-hydroxy-L-tyrosine (3-HTP).
    This reaction is typically carried out using hydrogen peroxide and a catalyst, such as sodium hydroxide or potassium hydroxide.


    Next, the 3-HTP is treated with a series of chemical reagents, including acetic anhydride, sodium acetate, hydrogen chloride, and sodium hydroxide, to produce carbidopa.
    The carbidopa is then treated with a solution of water and hydrochloric acid to produce carbidopa monohydrate.


    The final step in the synthesis of carbidopa monohydrate is the purification of the product.
    This is typically done using a series of chromatography techniques, such as high-performance liquid chromatography (HPLC) or column chromatography.
    These techniques are used to separate the carbidopa monohydrate from any impurities that may be present in the reaction mixture.


    Once the carbidopa monohydrate has been purified, it is typically dried and ground into a fine powder.
    This powder can then be used as an intermediate in the production of other chemicals and pharmaceuticals, or it can be used directly in the treatment of Parkinson's disease and other movement disorders.


    Carbidopa monohydrate is a commonly used intermediate in the production of other chemicals and pharmaceuticals, and it is also widely used in the treatment of Parkinson's disease and other movement disorders.
    The synthesis of carbidopa monohydrate involves a series of chemical reactions, which are typically carried out using various chemical reagents and catalysts.
    The purification of the carbidopa monohydrate is typically done using chromatography techniques, such as HPLC or column chromatography.


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.